These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19389929)

  • 1. Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.
    Szabo R; Kosa P; List K; Bugge TH
    Am J Pathol; 2009 Jun; 174(6):2015-22. PubMed ID: 19389929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.
    Nagaike K; Kawaguchi M; Takeda N; Fukushima T; Sawaguchi A; Kohama K; Setoyama M; Kataoka H
    Am J Pathol; 2008 Nov; 173(5):1464-75. PubMed ID: 18832587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
    Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
    Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal ichthyosis with hypotrichosis syndrome displays low matriptase proteolytic activity and is phenocopied in ST14 hypomorphic mice.
    List K; Currie B; Scharschmidt TC; Szabo R; Shireman J; Molinolo A; Cravatt BF; Segre J; Bugge TH
    J Biol Chem; 2007 Dec; 282(50):36714-23. PubMed ID: 17940283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
    Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H
    Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
    Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
    J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
    Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
    J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity.
    Kawaguchi M; Takeda N; Hoshiko S; Yorita K; Baba T; Sawaguchi A; Nezu Y; Yoshikawa T; Fukushima T; Kataoka H
    Am J Pathol; 2011 Oct; 179(4):1815-26. PubMed ID: 21840293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.
    Szabo R; Uzzun Sales K; Kosa P; Shylo NA; Godiksen S; Hansen KK; Friis S; Gutkind JS; Vogel LK; Hummler E; Camerer E; Bugge TH
    PLoS Genet; 2012; 8(8):e1002937. PubMed ID: 22952456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase.
    Kojima K; Tsuzuki S; Fushiki T; Inouye K
    J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.
    Szabo R; Molinolo A; List K; Bugge TH
    Oncogene; 2007 Mar; 26(11):1546-56. PubMed ID: 16983341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the polycystic kidney disease domain in matriptase chaperone activity and localization of hepatocyte growth factor activator inhibitor-1.
    Yamashita F; Kaieda T; Shimomura T; Kawaguchi M; Lin CY; Johnson MD; Tanaka H; Kiwaki T; Fukushima T; Kataoka H
    FEBS J; 2022 Jun; 289(12):3422-3439. PubMed ID: 35020274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin.
    Szabo R; Lantsman T; Peters DE; Bugge TH
    Development; 2016 Aug; 143(15):2818-28. PubMed ID: 27385010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
    Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
    Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase.
    Basel-Vanagaite L; Attia R; Ishida-Yamamoto A; Rainshtein L; Ben Amitai D; Lurie R; Pasmanik-Chor M; Indelman M; Zvulunov A; Saban S; Magal N; Sprecher E; Shohat M
    Am J Hum Genet; 2007 Mar; 80(3):467-77. PubMed ID: 17273967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2.
    Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK
    Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
    Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
    J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis.
    List K; Haudenschild CC; Szabo R; Chen W; Wahl SM; Swaim W; Engelholm LH; Behrendt N; Bugge TH
    Oncogene; 2002 May; 21(23):3765-79. PubMed ID: 12032844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice.
    Szabo R; Hobson JP; Christoph K; Kosa P; List K; Bugge TH
    Development; 2009 Aug; 136(15):2653-63. PubMed ID: 19592578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
    Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
    PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.